194 related articles for article (PubMed ID: 26093085)
1. DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation.
Faronato M; Nguyen VT; Patten DK; Lombardo Y; Steel JH; Patel N; Woodley L; Shousha S; Pruneri G; Coombes RC; Magnani L
Oncotarget; 2015 Sep; 6(26):22467-79. PubMed ID: 26093085
[TBL] [Abstract][Full Text] [Related]
2. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
[TBL] [Abstract][Full Text] [Related]
3. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
[TBL] [Abstract][Full Text] [Related]
4. Notch activation stimulates migration of breast cancer cells and promotes tumor growth.
Bolós V; Mira E; Martínez-Poveda B; Luxán G; Cañamero M; Martínez-A C; Mañes S; de la Pompa JL
Breast Cancer Res; 2013; 15(4):R54. PubMed ID: 23826634
[TBL] [Abstract][Full Text] [Related]
5. MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation.
Liang YK; Zeng D; Xiao YS; Wu Y; Ouyang YX; Chen M; Li YC; Lin HY; Wei XL; Zhang YQ; Kruyt FA; Zhang GJ
Cancer Lett; 2017 Feb; 386():65-76. PubMed ID: 27838413
[TBL] [Abstract][Full Text] [Related]
6. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
Trauernicht AM; Kim SJ; Kim NH; Boyer TG
Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
[TBL] [Abstract][Full Text] [Related]
7. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
8. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer.
Magnani L; Stoeck A; Zhang X; Lánczky A; Mirabella AC; Wang TL; Gyorffy B; Lupien M
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1490-9. PubMed ID: 23576735
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
11. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
13. The Interaction of the Senescent and Adjacent Breast Cancer Cells Promotes the Metastasis of Heterogeneous Breast Cancer Cells through Notch Signaling.
Zhang N; Ji J; Zhou D; Liu X; Zhang X; Liu Y; Xiang W; Wang M; Zhang L; Wang G; Huang B; Lu J; Zhang Y
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467780
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism.
Zielinska HA; Holly JMP; Bahl A; Perks CM
Cancer Lett; 2018 Apr; 419():187-202. PubMed ID: 29331414
[TBL] [Abstract][Full Text] [Related]
15. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.
Near RI; Zhang Y; Makkinje A; Vanden Borre P; Lerner A
J Cell Physiol; 2007 Sep; 212(3):655-65. PubMed ID: 17427198
[TBL] [Abstract][Full Text] [Related]
16. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
[TBL] [Abstract][Full Text] [Related]
17. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
Kong C; Wang C; Wang L; Ma M; Niu C; Sun X; Du J; Dong Z; Zhu S; Lu J; Huang B
PLoS One; 2011; 6(7):e22666. PubMed ID: 21829474
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
Kumar S; Srivastav RK; Wilkes DW; Ross T; Kim S; Kowalski J; Chatla S; Zhang Q; Nayak A; Guha M; Fuchs SY; Thomas C; Chakrabarti R
Oncogene; 2019 Mar; 38(12):2092-2107. PubMed ID: 30442981
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.
Rizzo P; Miao H; D'Souza G; Osipo C; Song LL; Yun J; Zhao H; Mascarenhas J; Wyatt D; Antico G; Hao L; Yao K; Rajan P; Hicks C; Siziopikou K; Selvaggi S; Bashir A; Bhandari D; Marchese A; Lendahl U; Qin JZ; Tonetti DA; Albain K; Nickoloff BJ; Miele L
Cancer Res; 2008 Jul; 68(13):5226-35. PubMed ID: 18593923
[TBL] [Abstract][Full Text] [Related]
20. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]